Source: Beximco Pharmaceuticals Ltd. (BXPHARMA) | FY 2017-18 | Page 83

### 32. Earnings Per Share (EPS)

Amount in Taka

| Particulars | Note | 2017-18 |
|---|---|---|
| (a) Earnings attributable to the Owners of the Company | | 2,536,543,948 |
| (b) Weighted average number of Shares outstanding during the year | | 405,556,445 |
| **Earnings Per Share (EPS)** | | **6.25** |

### 33. Net Asset Value (NAV) Per Share

Amount in Taka

| Particulars | Note | 2017-18 |
|---|---|---|
| Total Assets | | 43,738,886,412 |
| Less Total Liabilities | | (16,387,049,620) |
| Less Non-controlling Interest | | (269,874,176) |
| **Equity Attributable to the Owners of the Company** | | **27,081,962,616** |
| Number of Shares at Financial Position date | | 405,556,445 |
| **Net Asset Value (NAV) Per Share** | | **66.78** |

### 34. Net Operating Cash Flow Per Share (NOCFPS)

Amount in Taka

| Particulars | Note | 2017-18 |
|---|---|---|
| Net Cash Generated from Operating Activities | | 1,819,113,923 |
| Number of Shares at Financial Position date | | 405,556,445 |
| **Net Operating Cash Flow Per Share (NOCFPS)** | | **4.49** |

### 35. Reconciliation of Net Profit with Cash Flows from Operating Activities

Amount in Taka

| Particulars | Note | 2017-18 |
|---|---|---|
| **Profit after Tax** | | **2,532,654,301** |
| Adjustment to reconcile net profit to net cash provided by operating activities : | | |
| **(a) Non-cash Expenses :** | | **970,984,130** |
| Depreciation | | 801,715,192 |
| Amortization | | 44,193,967 |
| Gratuity & WPPF | | 57,650,531 |
| Technology Transfer Income - Biocare Manufacturing SDN. BHD., Malaysia | | (18,145,620) |
| Exchange rate fluctuation loss on Bank Loan in Foreign Currency | | 49,510,471 |
| Deferred Tax | | 36,059,589 |
| **(b) Non-operating Items** | | **2,022,847** |
| Dividend Income | | (1,504,092) |
| Loss on sale of Fixed Assets | | 3,526,939 |
| **(c) Changes in working Capital** | | **(1,686,547,355)** |
| (Increase)/Decrease in Inventories | | (1,192,022,631) |
| (Increase)/Decrease in Spares and Supplies | | (18,678,378) |
| (Increase)/Decrease in Accounts Receivable | | (566,040,570) |
| (Increase) in Loans, Advances & Deposits | | (365,849,712) |
| Increase/(Decrease) in Creditors and Other Payables | | 403,748,186 |
| Increase/(Decrease) in Accrued Expenses | | 41,306,104 |
| Increase/(Decrease) in Income Tax Payable | | 10,989,646 |
| **Net cash Generated from Operating Activities** | | **1,819,113,923** |